RxSight Appoints Raymond W. Cohen to Board of Directors

Strategic Insights -

RxSight, a leading ophthalmic medical device company, has appointed Raymond W. Cohen, a seasoned medical technology executive with over four decades of industry experience, to its Board of Directors. Cohen's extensive track record in leading and scaling medical technology companies will be invaluable as RxSight advances its strategy and enters the next phase of growth. His insights and guidance will help the company expand the reach of its flagship RxSight Light Adjustable Lens system, enabling more physicians and patients to benefit from truly customized vision after cataract surgery.

Key Takeaways:

  • Raymond W. Cohen, a veteran medical technology executive, joins RxSight's Board of Directors, bringing over 40 years of industry experience.
  • Cohen was the co-founder and CEO of Axonics, Inc., which generated over $1 billion in revenue within four years of its commercial launch and was acquired by Boston Scientific for $3.7 billion in 2024.
  • Cohen has also served on the boards of several innovative healthcare companies, including Kestra Medical Technologies, InspireMD, and Nalu Medical.
  • As Chairman of SoniVie, Ltd., Cohen led the sale of the company to Boston Scientific for $600 million in March 2025.
  • Cohen will support RxSight's mission to accelerate growth in revenue and profits, leveraging his expertise in leading and scaling medical technology companies.

Statistics:

  • RsxSight's RxSight Light Adjustable Lens system is the first and only commercially available intraocular lens technology that can be adjusted after surgery.
  • Axonics, Inc. generated over $1 billion in revenue within four years of its commercial launch.
  • Boston Scientific acquired Axonics, Inc. for $3.7 billion in 2024.
  • SoniVie, Ltd. was sold to Boston Scientific for $600 million by Cohen in March 2025.
  • RxSight has demonstrated exceptional outcomes for cataract surgery patients with its groundbreaking RxSight Light Adjustable Lens system.

Sources:

  • GlobeNewswire, RxSight Appoints Raymond W. Cohen to Board of Directors, August 4, 2025.
  • RxSight, Inc., About RxSight, Inc., accessed August 4, 2025.
  • Andera Partners, Venture Team, accessed August 4, 2025.